Vaccine News and Research

Latest Vaccine News and Research

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus Inc., a biopharmaceutical company developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced its financial results and business highlights for the fourth quarter and year ended December 31, 2013.

5 Mar 2014

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

HPV vaccine offers protection against cervical abnormalities in young women

The HPV vaccine offers significant protection against cervical abnormalities in young women, suggests a paper published on bmj.com today.

5 Mar 2014

Experimental drug nivolumab shrinks tumors in patients with advanced melanoma

An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.

4 Mar 2014

A-PARADDISE consortium obtains funds to develop innovative therapies for neglected parasitic diseases

The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.

4 Mar 2014

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON) and a leading global provider of temperature assurance packaging, has added frozen (less than minus 20 degrees Celsius) configurations to its popular Envoy Series of pre-qualified shippers.

4 Mar 2014

Loyola physician sheds light on common and painful viral infection, shingles

Shingles is a painful viral infection that affects almost one million people worldwide and 30 percent of Americans every year.

4 Mar 2014

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

The annual ritual of visiting a doctor's office or health clinic to receive a flu shot may soon be outdated, thanks to the findings of a new study published in the journal Vaccine.

4 Mar 2014

New findings point the way toward potentially more effective HIV vaccine

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2.

4 Mar 2014

Indonesia's commitment, investment in eliminating NTDs could lift millions of people out of poverty

The control and elimination of neglected tropical diseases (NTDs) is one of the most cost-effective ways Indonesia can sustain economic growth and reduce inequality, said scientists today in an analysis published in PLOS Neglected Tropical Diseases.

3 Mar 2014

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Seattle BioMed today announced that Jason Beaubien, global health and development correspondent of National Public Radio (NPR), will deliver the keynote address at the Passport to Global Health Celebration on March 5.

28 Feb 2014

Vaccine targeting tumors could initiate immune response to fight cancer

Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.

28 Feb 2014

Report: Spending on health care for children increased between 2009 and 2012

Spending on health care for children covered by employer-sponsored insurance (ESI) increased between 2009 and 2012, rising an average 5.5 percent a year, with more dollars spent on boys than girls, and higher spending on infants and toddlers (ages 0-3) than any other children's age group, finds a new report released today by the Health Care Cost Institute. Per capita spending on children reached $2,437 in 2012, a $363 increase from 2009. The study shows a growth in prescription use by children through age 18, as well as a rise in the number of teens being admitted for mental health and substance use (MHSU) treatment.

27 Feb 2014

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human antibodies that could hold the key to a vaccine for the world's most widespread mosquito-borne disease.

27 Feb 2014

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

27 Feb 2014

Somali Americans develop twice antibody response to rubella from current vaccine

Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response.

27 Feb 2014

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Protein M is a cell surface protein from Mycoplasma Genitalium that binds to all human antibodies.

26 Feb 2014

Fred Hutchinson, SCCA researchers receive Seattle Business Magazine's 2014 Leaders in Health Care Awards

Researchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) were recognized in several categories of Seattle Business Magazine's 2014 Leaders in Health Care Awards, including the publication's Lifetime Achievement Award, given to Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutch and president of SCCA.

26 Feb 2014

S. pneumoniae highly prevalent in urban Indonesians, especially children

Streptococcus pneumoniae is present in the nasopharyngeal mucosa in nearly half of children under the age of 5 years and one in 10 adults living in Java Island, Indonesia, a survey has found.

25 Feb 2014

Researchers identify polio-like syndrome in cluster of children from California

Researchers have identified a polio-like syndrome in a cluster of children from California over a one-year period, according to a case report released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

25 Feb 2014

Vaccine News and Research

Latest Vaccine News and Research

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

HPV vaccine offers protection against cervical abnormalities in young women

Experimental drug nivolumab shrinks tumors in patients with advanced melanoma

A-PARADDISE consortium obtains funds to develop innovative therapies for neglected parasitic diseases

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Loyola physician sheds light on common and painful viral infection, shingles

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

New findings point the way toward potentially more effective HIV vaccine

Indonesia's commitment, investment in eliminating NTDs could lift millions of people out of poverty

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Vaccine targeting tumors could initiate immune response to fight cancer

Report: Spending on health care for children increased between 2009 and 2012

Researchers discover new target for human antibodies that holds key to vaccine for dengue

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

Somali Americans develop twice antibody response to rubella from current vaccine

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Fred Hutchinson, SCCA researchers receive Seattle Business Magazine's 2014 Leaders in Health Care Awards

S. pneumoniae highly prevalent in urban Indonesians, especially children

Researchers identify polio-like syndrome in cluster of children from California

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in